Trial Profile
Prospective, Multi-center, Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2020
Price :
$35
*
At a glance
- Drugs Carvedilol (Primary)
- Indications Angina pectoris; Essential hypertension; Heart failure
- Focus Adverse reactions
- Acronyms DELIGHT
- Sponsors Chong Kun Dang
- 27 Feb 2017 New trial record